ArticleTherapeutic advances in endocrinology and metabolism2021
Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM.
Aml Mohamed Nada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2021
this papercites it